2026

Izquierdo-Sanchez, L. et al. (2026) Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry. Journal of Hepatology, (doi: 10.1016/j.jhep.2026.08.020) (PMID:42637053) (Early Online Publication)

Tesini, G. et al. (2026) IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers. JHEP Reports, 8(8), 101899. (doi: 10.1016/j.jhepr.2026.101899) (PMID:42167507)

2025

Tesini, Giulia, Ibrahim, Halima, Rimassa, Lorenza and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2025) Evolving precision: updates in targeted therapy for cholangiocarcinoma. Hepatology, (doi: 10.1097/HEP.0000000000001541) (PMID:40982790) (Early Online Publication)

Articles

Izquierdo-Sanchez, L. et al. (2026) Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry. Journal of Hepatology, (doi: 10.1016/j.jhep.2026.08.020) (PMID:42637053) (Early Online Publication)

Tesini, G. et al. (2026) IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers. JHEP Reports, 8(8), 101899. (doi: 10.1016/j.jhepr.2026.101899) (PMID:42167507)

Tesini, Giulia, Ibrahim, Halima, Rimassa, Lorenza and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2025) Evolving precision: updates in targeted therapy for cholangiocarcinoma. Hepatology, (doi: 10.1097/HEP.0000000000001541) (PMID:40982790) (Early Online Publication)